BackBlackRock Health Sciences Term Trust Overview

BlackRock Health Sciences Term Trust EBIT

Track BlackRock Health Sciences Term Trust's EBIT ($44M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$22.47M
357.95% YoY

As of Dec 31, 2024

Annual EBIT (TTM)

$43.53M

Trailing 12 months ending Dec 31, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

BlackRock Health Sciences Term Trust (BMEZ) FAQ

BlackRock Health Sciences Term Trust (BMEZ) currently reports a EBIT of $44M as of December 2024. That is above the sector sector average of $-6.4M. Use the charts on this page to explore BlackRock Health Sciences Term Trust's EBIT history and peer comparisons.

BlackRock Health Sciences Term Trust's EBIT of $44M is higher than the its sector sector average of $-6.4M. That is roughly 779.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

BlackRock Health Sciences Term Trust reported $44M in EBIT as of December 2024. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $44M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-6.4M. From there, open related valuation or income-statement pages for BlackRock Health Sciences Term Trust, and consider following BMEZ for alerts when major investors trade the stock.